1.Family-perceived usefulness of a pamphlet for families of imminently dying patients: a multicenter study
Ryo Yamamoto ; Hiroyuki Otani ; Naoki Matsuo ; Takuya Shinjo ; Satsuki Uno ; Hikaru Hirose ; Tatsuhiro Matsubara ; Chizuko Takigawa ; Hiroshi Maeno ; Kazuyoshi Sasaki ; Yoshikazu Chinone ; Masayuki Ikenaga ; Tatsuya Morita
Palliative Care Research 2012;7(2):192-201
Purpose: To clarify the family-perceived usefulness of a pamphlet for families of imminently dying patients. Methods: Physicians and/or nurses provided medical and practical information about the dying process using a pamphlet for families of imminently dying patients. We surveyed family members 6 months after the death of the patient about the perceived usefulness. Results: We sent out a questionnaire to 325 bereaved, and obtained an answer from 260 (response rate: 85%). Overall, 81% reported the pamphlet to be “very useful” or “useful”. The experience reported by the bereaved included: “Helped me to understand the dying process” (84%); “Helped me to understand how symptoms and changes occur” (76%), “Useful in preparation for patient's death“ (75%), “Helped me to understand the physical conditions of the patient” (75%), “Helped me to know what I can do for the patient” (74%). Conclusion: “A pamphlet for families of imminently dying patients” may be useful for members of an imminently dying patient's family.
2.Patient-related Factors Contributing to Shorter Prognosis than Oncologist’s Estimation of Survival in Terminal Cancer
Yoko OHBA ; Teruaki TANAKA ; Masako SATO ; Isao YOKOTA ; Chizuko TAKIGAWA
Palliative Care Research 2021;16(4):307-314
Objective: To investigate the factors that make observed survival of patients with terminal cancer shorter than oncologists’ estimation. Methods: We retrospectively surveyed the medical records of terminal cancer patients who were referred to our palliative care unit with a predicted survival of 1–3 months and discharged dead from hospital within 3 months. Results: A total of 249 patients were eligible for analysis. One hundred and two patients (41%) had observed survival of less than one month (OS1), and 147 (59%) lived for 1–3 months (OS1–3) as expected. Depressed level of consciousness above Japan Coma Scale II and severely reduced oral intake (a few mouthfuls or less) were associated with unexpected shorter survival. The number of patients who died within two days after sudden deterioration of general condition was significantly higher in OS1 than OS1–3. Conclusion: Although survival of patients with the above factors may be shorter than oncologists’ estimation, it is necessary to examine the physician-side factors that contribute to the inaccuracy of prognosis.